Literature DB >> 21547439

Inverse correlation of programmed death 1 (PD-1) expression in T cells to the spinal radiologic changes in Taiwanese patients with ankylosing spondylitis.

Ming-Han Chen1, Wei-Sheng Chen, Hui-Ting Lee, Chang-Youh Tsai, Chung-Tei Chou.   

Abstract

Programmed death 1 (PD-1) has been shown to be involved in the negative regulation of the immune response. However, the role of PD-1 in ankylosing spondylitis (AS) has not been studied. Therefore, we analyzed the expression of PD-1 in peripheral blood mononuclear cells (PBMC) from patients with AS. Twenty-three AS patients, 20 rheumatoid arthritis (RA) patients, and 25 normal healthy subjects were recruited. The percentage of the PBMC and PD-1 levels in these subjects were measured by flow cytometry. A higher percentage of CD4+ T cells was noted in AS patients than in healthy controls (37.53±1.65% vs. 31.55±0.92%, P<0.01), but a similar result was not observed with regard to CD3+ T lymphocytes, CD4+CD25 high+regulatory T cells, CD19+ B cells, and CD14+ and CD16+ monocytes/macrophages. PD-1 levels in PBMC were not significantly higher in AS patients than in RA patients or age- and gender-matched healthy controls and were also not correlated to the erythrocyte sedimentation rate, C-reactive protein, limitation of back flexion, and chest expansion in patients with AS. Of interest, the percentages of PD-1+CD3+ T cells and PD-1+CD4+ T cells were significantly lower in AS patients with higher modified Stokes Ankylosing Spondylitis Spinal Scores (mSASSS ≥30) than in those with lower mSASSS (<30; 0.07±0.04% vs. 0.42±0.14%, P<0.05; 0.06±0.03% vs. 0.40±0.14%, P<0.05, respectively). These results have suggested that the increased number of T helper cells lacking PD-1 may contribute to the spinal radiologic changes in AS patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21547439     DOI: 10.1007/s10067-011-1721-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  33 in total

Review 1.  HLA-B27 and its pathogenic role.

Authors:  Muhammad Asim Khan
Journal:  J Clin Rheumatol       Date:  2008-02       Impact factor: 3.517

2.  Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells.

Authors:  Christian Mottet; Holm H Uhlig; Fiona Powrie
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

3.  Programmed death-1 gene polymorphisms in patients with systemic lupus erythematosus in Taiwan.

Authors:  Shu-Chen Wang; Yi-Jing Chen; Tsan-Teng Ou; Cheng-Chin Wu; Wen-Chan Tsai; Hong-Wen Liu; Jeng-Hsien Yen
Journal:  J Clin Immunol       Date:  2006-10-06       Impact factor: 8.317

4.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

5.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

6.  Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.

Authors:  Y Agata; A Kawasaki; H Nishimura; Y Ishida; T Tsubata; H Yagita; T Honjo
Journal:  Int Immunol       Date:  1996-05       Impact factor: 4.823

7.  Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndrome.

Authors:  Masaya Kobayashi; Seiji Kawano; Saori Hatachi; Chiyo Kurimoto; Taku Okazaki; Yoshiko Iwai; Tasuku Honjo; Yoshimasa Tanaka; Nagahiro Minato; Takahide Komori; Sakan Maeda; Shunichi Kumagai
Journal:  J Rheumatol       Date:  2005-11       Impact factor: 4.666

8.  CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms.

Authors:  Richard V Parry; Jens M Chemnitz; Kenneth A Frauwirth; Anthony R Lanfranco; Inbal Braunstein; Sumire V Kobayashi; Peter S Linsley; Craig B Thompson; James L Riley
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

9.  Increased expression of CD154 (CD40L) on stimulated T-cells from patients with psoriatic arthritis.

Authors:  D Daoussis; I Antonopoulos; A P Andonopoulos; S-N C Liossis
Journal:  Rheumatology (Oxford)       Date:  2006-07-22       Impact factor: 7.580

10.  Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

Authors:  Y Ishida; Y Agata; K Shibahara; T Honjo
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  9 in total

Review 1.  The associations between PD-1, CTLA-4 gene polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis and systemic review.

Authors:  Si Chen; Yuan Li; Chuiwen Deng; Jing Li; Xiaoting Wen; Ziyan Wu; Chaojun Hu; Shulan Zhang; Ping Li; Xuan Zhang; Fengchun Zhang; Yongzhe Li
Journal:  Rheumatol Int       Date:  2015-08-01       Impact factor: 2.631

2.  The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis.

Authors:  Takayoshi Morita; Yoshihito Shima; James Badger Wing; Shimon Sakaguchi; Atsushi Ogata; Atsushi Kumanogoh
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

3.  The design of high affinity human PD-1 mutants by using molecular dynamics simulations (MD).

Authors:  Jiangfeng Du; Yaping Qin; Yahong Wu; Wenshan Zhao; Wenjie Zhai; Yuanming Qi; Chuchu Wang; Yanfeng Gao
Journal:  Cell Commun Signal       Date:  2018-06-07       Impact factor: 5.712

Review 4.  The Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis: A Meta-Analysis.

Authors:  Na-Lin Lai; Sheng-Xiao Zhang; Jia Wang; Jia-Qian Zhang; Cai-Hong Wang; Chong Gao; Xiao-Feng Li
Journal:  J Immunol Res       Date:  2019-10-23       Impact factor: 4.818

Review 5.  The Potential Role of Genetics, Environmental Factors, and Gut Dysbiosis in the Aberrant Non-Coding RNA Expression to Mediate Inflammation and Osteoclastogenic/Osteogenic Differentiation in Ankylosing Spondylitis.

Authors:  Hsien-Tzung Liao; Chang-Youh Tsai; Chien-Chih Lai; Song-Chou Hsieh; Yi-Syuan Sun; Ko-Jen Li; Chieh-Yu Shen; Cheng-Han Wu; Cheng-Hsun Lu; Yu-Min Kuo; Tzu-Hao Li; Chung-Tei Chou; Chia-Li Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-20

6.  Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumab.

Authors:  Tomoko Yamamoto Funazo; Takashi Nomizo; Hiroaki Ozasa; Takahiro Tsuji; Yuto Yasuda; Hironori Yoshida; Yuichi Sakamori; Hiroki Nagai; Toyohiro Hirai; Young Hak Kim
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

Review 7.  Meta-Analysis of Changes in the Number and Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis.

Authors:  Ming Li; Xueping Zhou; Lingling Zhou; Zhichao Yu; Ling Fu; Pei Yang
Journal:  Biomed Res Int       Date:  2020-02-19       Impact factor: 3.411

Review 8.  B Cell Involvement in the Pathogenesis of Ankylosing Spondylitis.

Authors:  Rick Wilbrink; Anneke Spoorenberg; Gwenny M P J Verstappen; Frans G M Kroese
Journal:  Int J Mol Sci       Date:  2021-12-11       Impact factor: 5.923

9.  Imbalance of Peripheral Lymphocyte Subsets in Patients With Ankylosing Spondylitis: A Meta-Analysis.

Authors:  Dong Liu; Budian Liu; Churong Lin; Jieruo Gu
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.